These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 28853218)
1. Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic/cytogenetic features in children with B-precursor acute lymphoblastic leukemia. Liang DC; Chen SH; Liu HC; Yang CP; Yeh TC; Jaing TH; Hung IJ; Hou JY; Lin TH; Lin CH; Shih LY Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28853218 [TBL] [Abstract][Full Text] [Related]
2. Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. Paulsson K; Horvat A; Strömbeck B; Nilsson F; Heldrup J; Behrendtz M; Forestier E; Andersson A; Fioretos T; Johansson B Genes Chromosomes Cancer; 2008 Jan; 47(1):26-33. PubMed ID: 17910045 [TBL] [Abstract][Full Text] [Related]
3. Impact of mutations in FLT3, PTPN11 and RAS genes on the overall survival of pediatric B cell precursor acute lymphoblastic leukemia in Brazil. Barbosa TC; Andrade FG; Lopes BA; de Andrade CF; Mansur MB; Emerenciano M; Pombo-de-Oliveira MS Leuk Lymphoma; 2014 Jul; 55(7):1501-9. PubMed ID: 24067137 [TBL] [Abstract][Full Text] [Related]
4. Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia. Al-Kzayer LF; Sakashita K; Al-Jadiry MF; Al-Hadad SA; Ghali HH; Uyen le TN; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Sughayer MA; Rihani R; Madanat FF; Inoshita T; Kamata M; Koike K Pediatr Blood Cancer; 2015 Dec; 62(12):2157-61. PubMed ID: 26222068 [TBL] [Abstract][Full Text] [Related]
5. Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan. Yen HJ; Chen SH; Chang TY; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Chang TK; Peng CT; Lin MT; Jaing TH; Liu HC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Hung GY; Wu KH; Yeh TC; Wang SC; Chen RL; Chang HH; Yang YL; Chen SH; Cheng SN; Chang YH; Chen BW; Hsieh YL; Huang FL; Ho WL; Wang JL; Chang CY; Chao YH; Lin PC; Chen YC; Liao YM; Lin TH; Shih LY; Liang DC Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436581 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of RAS pathway mutations in juvenile myelomonocytic leukaemia: a single-institution study from Korea. Kim HS; Lee JW; Kang D; Yu H; Kim Y; Kang H; Lee JM; Ahn A; Cho B; Kim S; Chung NG; Kim Y; Kim M Br J Haematol; 2021 Dec; 195(5):748-756. PubMed ID: 34590720 [TBL] [Abstract][Full Text] [Related]
7. Tobacco Smoke and Ras Mutations Among Latino and Non-Latino Children with Acute Lymphoblastic Leukemia. Kaur M; de Smith AJ; Selvin S; Zhang L; Cunningham M; Kang MW; Hansen HM; Cooper RM; McKean-Cowdin R; Wiemels JL; Metayer C Arch Med Res; 2016 Nov; 47(8):677-683. PubMed ID: 28476195 [TBL] [Abstract][Full Text] [Related]
8. Juvenile myelomonocytic leukemia: who's the driver at the wheel? Niemeyer CM; Flotho C Blood; 2019 Mar; 133(10):1060-1070. PubMed ID: 30670449 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of Coexisting Gene with NRAS in Acute Myeloid Leukemia]. Sheng YP; Hua HY; Chao HY; Zhu WY; Wang ZQ; Zhang Y; Zhou Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):351-356. PubMed ID: 35395962 [TBL] [Abstract][Full Text] [Related]
10. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. Sakhdari A; Thakral B; Loghavi S; Kanagal-Shamanna R; Yin CC; Zuo Z; Routbort MJ; Luthra R; Medeiros LJ; Wang SA; Patel KP; Ok CY Cancer Med; 2020 Feb; 9(3):849-858. PubMed ID: 31804006 [TBL] [Abstract][Full Text] [Related]
11. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements. Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population. Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113 [TBL] [Abstract][Full Text] [Related]
13. Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer. Schirripa M; Cremolini C; Loupakis F; Morvillo M; Bergamo F; Zoratto F; Salvatore L; Antoniotti C; Marmorino F; Sensi E; Lupi C; Fontanini G; De Gregorio V; Giannini R; Basolo F; Masi G; Falcone A Int J Cancer; 2015 Jan; 136(1):83-90. PubMed ID: 24806288 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials. Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686 [TBL] [Abstract][Full Text] [Related]
15. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes. Messina M; Chiaretti S; Wang J; Fedullo AL; Peragine N; Gianfelici V; Piciocchi A; Brugnoletti F; Di Giacomo F; Pauselli S; Holmes AB; Puzzolo MC; Ceglie G; Apicella V; Mancini M; Te Kronnie G; Testi AM; Vitale A; Vignetti M; Guarini A; Rabadan R; Foà R Oncotarget; 2016 Mar; 7(12):13886-901. PubMed ID: 26883104 [TBL] [Abstract][Full Text] [Related]
16. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518 [TBL] [Abstract][Full Text] [Related]
17. Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing. Zhang H; Wang H; Qian X; Gao S; Xia J; Liu J; Cheng Y; Man J; Zhai X BMC Cancer; 2020 Mar; 20(1):211. PubMed ID: 32164600 [TBL] [Abstract][Full Text] [Related]
18. Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia. Park HD; Lee SH; Sung KW; Koo HH; Jung NG; Cho B; Kim HK; Park IA; Lee KO; Ki CS; Kim SH; Yoo KH; Kim HJ Ann Hematol; 2012 Apr; 91(4):511-7. PubMed ID: 21901340 [TBL] [Abstract][Full Text] [Related]
19. RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia. Jerchel IS; Hoogkamer AQ; Ariës IM; Steeghs EMP; Boer JM; Besselink NJM; Boeree A; van de Ven C; de Groot-Kruseman HA; de Haas V; Horstmann MA; Escherich G; Zwaan CM; Cuppen E; Koudijs MJ; Pieters R; den Boer ML Leukemia; 2018 Apr; 32(4):931-940. PubMed ID: 28972594 [TBL] [Abstract][Full Text] [Related]
20. Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia. Yoshida N; Yagasaki H; Xu Y; Matsuda K; Yoshimi A; Takahashi Y; Hama A; Nishio N; Muramatsu H; Watanabe N; Matsumoto K; Kato K; Ueyama J; Inada H; Goto H; Yabe M; Kudo K; Mimaya J; Kikuchi A; Manabe A; Koike K; Kojima S Pediatr Res; 2009 Mar; 65(3):334-40. PubMed ID: 19047918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]